…has demonstrated moderately satisfactory results, with compliance to individual recommendations of the order of 74-90%, and to the whole list of recommendations of 49%, indicating some room for further improvement….
…1-year all-cause mortality, dyspnoea, anxiety, and depression (Sarwar 2022) [evidence level I]. Meta-analysis of the 4 COPD-only studies demonstrated a significant improvement in SGRQ -5.82 (95% CI -9.17 to -2.47)….
…2003). They were unable to identify any evidence to support the use of peak flow charts to assess treatment with inhaled corticosteroids in patients with pre-diagnosed COPD. Studies were found…
…for financial matters, as well as an EPOA for medical management. There are multiple online resources, e.g. from the Office of the Public Advocate in Victoria: http://www.publicadvocate.vic.gov.au/, but these are…
…and baseline PaCO2 were not performed. In the stable COPD group, quality of life scores improved with NIV, after three months (SMD 0.39, 95% CI 0.15-0.62; 5 studies, 259 participants);…
…(Peto OR 0.71; 95% CI 0.56-0.91), and low-dose ICSs (Peto OR 0.88; 95% CI 0.79-0.97), and budesonide (Peto OR, 0.75; 95% CI 0.59-0.94) were involved in this association. Eosinophil counts…
…eosinophil count ≥0.34×109). Outcomes were better overall for eosinophilic AECOPD, with decreased hospital mortality (OR0.59, 95% CI 0.31-0.95,p=0.03), decreased length of stay ( OR=0.72,95% CI-1.44 to -0.00,p=0.05), higher FEV1 (mean…
…Physiotherapist, Prince of Wales Hospital, Sydney, NSW No conflicts to declare Professor Christine F McDonald, AM, FAHMS, MBBS(Hons), PhD, FRACP, FThorSoc, Director, Department of Respiratory and Sleep Medicine,…
…1,000 patients and prospectively found its presence lead to an significantly increased risk of future exacerbations odds ratio, 3.44; 95% CI 2.78 to 4.25; p<0.001 (Wells 2012) [evidence level III-2]….
…Subsequently, subanalysis of the Canadian Cohort Obstructive Lung Disease (CanCOLD) data (n=1561) has demonstrated a higher prevalence (adjusted OR 1.55 (1.04-2.31), p=0.033) and incidence (HR 2.09 (1.10-3.98, p=0.024)) of CVD…